[go: up one dir, main page]

GT200600391A - Composiciones de liposomas - Google Patents

Composiciones de liposomas

Info

Publication number
GT200600391A
GT200600391A GT200600391A GT200600391A GT200600391A GT 200600391 A GT200600391 A GT 200600391A GT 200600391 A GT200600391 A GT 200600391A GT 200600391 A GT200600391 A GT 200600391A GT 200600391 A GT200600391 A GT 200600391A
Authority
GT
Guatemala
Prior art keywords
liposomas
hydro
liposomes
polymer
linked
Prior art date
Application number
GT200600391A
Other languages
English (en)
Inventor
Saran Kumar
Wenlei Jiang
Joerg Ogorka
Jia-Ai Zhang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37715942&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200600391(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT200600391A publication Critical patent/GT200600391A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE DA A CONOCER UN MÉTODO DE TERAPIA BASADA EN LIPOSOMAS PARA UN SUJETO MAMÍFERO. EL MÉTODO UTILIZA LIPOSOMAS Y/O LIPOSOMAS CON SUPERFICIES EXTERNAS QUE CONTIENEN UNA FRACCIÓN DE AFINIDAD EFECTIVA PARA ENLAZARSE ESPECÍFICAMENTE A UNA SUPERFICIE BIOLÓGICA HACIA LA CUAL SE DIRIGE LA TERAPIA, Y UN RECUBRIMIENTO POLIMÉRICO HIDROFÍLICO. EL RECUBRIMIENTO POLIMÉRICO HIDROFÍLICO SE FORMA DE CADENAS POLIMÉRICAS CONVALENTEMENTE ENLAZADAS A LOS COMPONENTES DE LÍPIDO SUPERFICIALES. DESPUÉS DE QUE SE LOGRA UNA BIODISTRIBUCIÓN DE LIPOSOMAS DESEADA, EL AGENTE DE AFINIDAD SE ENLAZA A LA SUPERFICIE OBJETIVA, Y AYUDA A INTERNALIZAR LOS LIPOSOMAS. T2006
GT200600391A 2005-09-01 2006-08-30 Composiciones de liposomas GT200600391A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71327305P 2005-09-01 2005-09-01

Publications (1)

Publication Number Publication Date
GT200600391A true GT200600391A (es) 2007-04-02

Family

ID=37715942

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600391A GT200600391A (es) 2005-09-01 2006-08-30 Composiciones de liposomas

Country Status (14)

Country Link
US (1) US20080286352A1 (es)
EP (1) EP1924247A2 (es)
JP (1) JP2009507029A (es)
KR (1) KR20080038379A (es)
CN (1) CN101252912A (es)
AR (1) AR055621A1 (es)
AU (1) AU2006284642A1 (es)
BR (1) BRPI0616598A2 (es)
CA (1) CA2620400A1 (es)
GT (1) GT200600391A (es)
PE (1) PE20070360A1 (es)
RU (1) RU2008111967A (es)
TW (1) TW200744669A (es)
WO (1) WO2007028020A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123258A1 (en) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes for drug delivery
WO2010143193A1 (en) * 2009-06-11 2010-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Targeted liposomes comprising n-containing bisphosphonates and uses thereof
WO2011038073A1 (en) * 2009-09-23 2011-03-31 Formatech, Inc. Methods for the preparation of liposomes comprising docetaxel
US10143652B2 (en) * 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
CN102038641B (zh) * 2009-10-26 2013-04-17 石药集团中奇制药技术（石家庄）有限公司 一种外层经亲水聚合物修饰的脂质体药物的制备方法
ITNA20100046A1 (it) * 2010-09-28 2012-03-29 Abbruzzese Saccardi Alberto Uso di bisfosfonati per la preparazione di formulazioni farmaceutiche per il trattamento dei sintomi associati a dolore neuropatico
IT1401882B1 (it) * 2010-10-01 2013-08-28 Rosa De Nanoparticelle autoassemblanti per il rilascio di bifosfonati nel trattamento di tumori.
WO2013009701A2 (en) 2011-07-08 2013-01-17 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
EP2823811A1 (en) 2013-07-09 2015-01-14 OTC GmbH Targeted active release system comprising solid lipid nano-particles
WO2015043613A1 (en) 2013-09-26 2015-04-02 Biontech Ag Particles comprising a shell with rna
WO2015069926A1 (en) 2013-11-06 2015-05-14 The University Of Chicago Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers
EP3439666A4 (en) 2016-05-20 2019-12-11 The University of Chicago NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY AND ALL COMBINATIONS THEREOF
MX2019012699A (es) * 2017-04-28 2020-12-11 Texas Childrens Hospital Nanoparticulas dirigidas.
CN111194232B (zh) 2017-08-02 2023-01-31 芝加哥大学 纳米级金属有机层和金属有机纳米片
WO2020207472A1 (zh) * 2019-04-11 2020-10-15 厦门万泰沧海生物技术有限公司 唑来膦酸锌微纳米颗粒佐剂的制备及作为疫苗佐剂的用途
TWI763991B (zh) * 2019-05-02 2022-05-11 行政院原子能委員會核能研究所 新式眼用凝膠及其製備方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69816778T2 (de) * 1997-09-09 2004-04-15 Lyotropic Therapeutics, Inc. Beschichtete teilchen, methode zu ihrer herstellung und verwendung
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6426086B1 (en) * 1998-02-03 2002-07-30 The Regents Of The University Of California pH-sensitive, serum-stable liposomes
AU1525700A (en) * 1998-11-19 2000-06-05 Board Of Trustees Of The University Of Arkansas, The Increasing bone strength with selected bisphosphonates
US6852334B1 (en) * 1999-04-20 2005-02-08 The University Of British Columbia Cationic peg-lipids and methods of use
PT1178810E (pt) * 1999-05-21 2005-08-31 Novartis Ag Utilizacao de acidos bisfosfonicos para o tratamento de angiogenese
US7090865B2 (en) * 2001-11-29 2006-08-15 National Jewish Medical And Research Center Composition and method for treating autoimmune hemolytic anemia
CA2536393A1 (en) * 2003-09-09 2005-06-16 Gilead Sciences, Inc. Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample

Also Published As

Publication number Publication date
BRPI0616598A2 (pt) 2011-06-28
AU2006284642A1 (en) 2007-03-08
TW200744669A (en) 2007-12-16
EP1924247A2 (en) 2008-05-28
CA2620400A1 (en) 2007-03-08
US20080286352A1 (en) 2008-11-20
AR055621A1 (es) 2007-08-29
WO2007028020A2 (en) 2007-03-08
JP2009507029A (ja) 2009-02-19
WO2007028020A3 (en) 2007-05-31
PE20070360A1 (es) 2007-04-19
KR20080038379A (ko) 2008-05-06
RU2008111967A (ru) 2009-10-10
CN101252912A (zh) 2008-08-27

Similar Documents

Publication Publication Date Title
GT200600391A (es) Composiciones de liposomas
AR062452A1 (es) Composiciones en nanoparticulas
ES2523589T3 (es) Procedimiento para el revestimiento de superficies metálicas con una composición de material lubricante
AR109500A2 (es) Composiciones de tigeciclina y métodos de preparación
BRPI0509505A (pt) método e kit útil para branqueamento de uma superfìcie dental
AR052186A1 (es) Composiciones de recubrimiento acuosas
BRPI0507031A (pt) composições nematocidas e métodos de uso dessas
EP1931369A4 (en) PROCESS FOR REDUCING CD36 EXPRESSION
ECSP099027A (es) Anticuerpos anti-dll4 y métodos que los usan
AR065646A1 (es) Procedimiento para el recubrimiento de superficies metalicas con una composicion acuosa que contiene polimeros, la composicion acuosa y el uso de los substratos recubiertos
AR050539A1 (es) Proceso de sombreado y composicion de sombreado que comprende una ftalocianina
WO2005123781A3 (de) Wasserabsorbierendes polysaccharid sowie ein verfahren zu seiner herstellung
AR067495A1 (es) Composiciones farmaceuticas y procedimientode tratamientos de trastornos de ojo seco
CR20120384A (es) Composición de farmaco conjugado
AR048251A1 (es) Metodos para preparar y utilizar macroparticulas revestidas
AR040302A1 (es) Dispositivos para la liberacion transdermica de farmacos, que presentan microprotrusiones recubiertas
MX2007000611A (es) Tratamiento de la piel con luz y un agente benefico para mitigar el acne.
AR058037A1 (es) Dispersion por aplicacion de una capa metalica
AR066336A1 (es) Uso de elastomeros liquidos curables para producir geles para tratar una luz de pozo
GB2454855A (en) Method of forming a high friction joint
AR042299A1 (es) Composicion de tratamiento de superficie para substratos blandos
AR060281A1 (es) Composicion para un pretratamiento de espuma para instrumentos medicos
ES2193291T3 (es) Uso de composiciones acuosas de revestimiento protectoras para revestimientos industriales y composiciones acuosas de revestimiento.
AR058579A1 (es) Proceso para preparar desvenlafaxina
AR056500A1 (es) Metodo para preparar una composicion medica